Your browser doesn't support javascript.
loading
Partial lipodystrophy of the limbs in a diabetes clinic setting.
Demir, Tevfik; Akinci, Baris; Demir, Leyla; Altay, Canan; Atik, Tahir; Cavdar, Umit; Secil, Mustafa; Comlekci, Abdurrahman.
Afiliación
  • Demir T; Dokuz Eylul University, Division of Endocrinology, Izmir, Turkey.
  • Akinci B; Dokuz Eylul University, Division of Endocrinology, Izmir, Turkey. Electronic address: barisakincimd@gmail.com.
  • Demir L; Ataturk Training Hospital, Department of Biochemistry, Izmir, Turkey.
  • Altay C; Dokuz Eylul University, Department of Radiology, Izmir, Turkey.
  • Atik T; Ege University, Department of Pediatric Genetics, Izmir, Turkey.
  • Cavdar U; Dokuz Eylul University, Division of Endocrinology, Izmir, Turkey.
  • Secil M; Dokuz Eylul University, Department of Radiology, Izmir, Turkey.
  • Comlekci A; Dokuz Eylul University, Division of Endocrinology, Izmir, Turkey.
Prim Care Diabetes ; 10(4): 293-9, 2016 08.
Article en En | MEDLINE | ID: mdl-26776282
ABSTRACT

OBJECTIVE:

Partial lipodystrophy of the limbs (PLL) is a newly described form of lipodystrophy that is characterized by symmetrical distal lipoatrophy of the limbs and insulin resistant diabetes. RESEARCH DESIGN AND

METHODS:

In this study, we prospectively screened our patients with type 2 diabetes for the presence of PLL phenotype. Metabolic parameters of PLL patients were compared to those with type 2 diabetes who applied to our diabetes clinic during the same period of time.

RESULTS:

Between Sep 2013 and Mar 2015, 2020 patients with type 2 diabetes were evaluated for the presence of PLL. PLL was confirmed in 16 patients. The prevalence of PLL was calculated as 0.79% in our diabetes clinic. The most common phenotypic presentations were loss of subcutaneous fat in the forearms, calves and thighs, and loss of fat in forearms and calves. Patients with PLL had poor metabolic control and marked insulin resistance compared to subjects with type 2 diabetes. Diabetes had been diagnosed at a younger age in patients with PLL. Patients with PLL also had more atherogenic lipid profiles.

CONCLUSIONS:

Our data suggests that PLL is a relatively common form of lipodystrophy in diabetes clinics, which is associated with poor metabolic control and marked insulin resistance. The recognition of PLL in patients with type 2 diabetes can help better clinical management by alerting the physician to these associated co-morbidities.
Asunto(s)
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 / Grasa Subcutánea / Adiposidad / Instituciones de Atención Ambulatoria / Lipodistrofia Tipo de estudio: Diagnostic_studies / Etiology_studies / Observational_studies / Prevalence_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged País/Región como asunto: Asia Idioma: En Revista: Prim Care Diabetes Asunto de la revista: ENDOCRINOLOGIA Año: 2016 Tipo del documento: Article País de afiliación: Turquía

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 / Grasa Subcutánea / Adiposidad / Instituciones de Atención Ambulatoria / Lipodistrofia Tipo de estudio: Diagnostic_studies / Etiology_studies / Observational_studies / Prevalence_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged País/Región como asunto: Asia Idioma: En Revista: Prim Care Diabetes Asunto de la revista: ENDOCRINOLOGIA Año: 2016 Tipo del documento: Article País de afiliación: Turquía